Question

What incentives does the FDA have regarding drug approvals, according to some FDA critics?

		The FDA is more concerned with preventing approval of a drug that results in people dying than it is with approving a drug that benefits unidentifiable patients whose lives might be saved if the drug is approved earlier.
		The FDA is more concerned with preventing statistical deaths than with “visible” or “identifiable” lives.
		The FDA is too quick to approve new drugs because of pressure from drug manufacturers.
		The FDA spends too much of its resources on post-marketing surveillance of drugs instead of on the drug approval process.

Answer 1

Answer:The FDA is too quick to approve new drug because of pressure from drug manufacturers.

Reason:

Good and Drug administration FDA allow unsade drug on the market because of pressure from pheumaceutical meenafactures companies tail to ensure in drug storage and labelling, and allow use of dargirous chenicals